Does MOSUNETUZUMAB Cause Rash maculo-papular? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Rash maculo-papular have been filed in association with MOSUNETUZUMAB (Lunsumio Velo). This represents 1.0% of all adverse event reports for MOSUNETUZUMAB.
5
Reports of Rash maculo-papular with MOSUNETUZUMAB
1.0%
of all MOSUNETUZUMAB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Rash maculo-papular From MOSUNETUZUMAB?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Rash maculo-papular Listed in the Official Label?
Yes, Rash maculo-papular is listed as a known adverse reaction in the official FDA drug label for MOSUNETUZUMAB.
What Other Side Effects Does MOSUNETUZUMAB Cause?
Cytokine release syndrome (96)
Disease progression (65)
Covid-19 (50)
Neutropenia (39)
Death (38)
Covid-19 pneumonia (37)
Malignant neoplasm progression (37)
Disorientation (31)
Neurological symptom (31)
Vasogenic cerebral oedema (31)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which MOSUNETUZUMAB Alternatives Have Lower Rash maculo-papular Risk?
MOSUNETUZUMAB vs MOSUNETUZUMAB-AXGB
MOSUNETUZUMAB vs MOXIFLOXACIN
MOSUNETUZUMAB vs MOXIFLOXACIN\MOXIFLOXACIN
MOSUNETUZUMAB vs MOXONIDINE
MOSUNETUZUMAB vs MS CONTIN